ProfileGDS4718 / 227025_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 59% 61% 62% 62% 62% 63% 62% 60% 62% 63% 65% 68% 62% 68% 58% 64% 60% 70% 55% 64% 65% 63% 68% 65% 58% 59% 67% 65% 68% 56% 63% 66% 68% 63% 69% 58% 59% 61% 64% 63% 61% 60% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5180566
GSM549102patient 115, normal, homogenized [OPG study]6.0536359
GSM549104patient 119, normal, homogenized [OPG study]6.2027561
GSM549108patient 138, normal, homogenized [OPG study]6.2983562
GSM549119patient 077, normal, homogenized [OPG study]6.2452862
GSM549133patient 032, cancer, homogenized [OPG study]6.2808762
GSM549139patient 042, cancer, homogenized [OPG study]6.3209563
GSM549099patient 107, normal, homogenized [OPG study]6.2516362
GSM549109patient 139, normal, homogenized [OPG study]6.1564960
GSM549110patient 046, normal, homogenized [OPG study]6.2660862
GSM549114patient 063, normal, homogenized [OPG study]6.2717563
GSM549122patient 082, normal, homogenized [OPG study]6.5278465
GSM549134patient 033, cancer, homogenized [OPG study]6.7365768
GSM549136patient 036, cancer, homogenized [OPG study]6.2651562
GSM549140patient 044, cancer, homogenized [OPG study]6.7132468
GSM549111patient 047, normal, homogenized [OPG study]5.9870758
GSM549113patient 057, normal, homogenized [OPG study]6.3591664
GSM549132patient 031, cancer, homogenized [OPG study]6.1427760
GSM549137patient 038, cancer, homogenized [OPG study]6.9169470
GSM549142patient 047, cancer, homogenized [OPG study]5.9350655
GSM549100patient 110, normal, homogenized [OPG study]6.4064264
GSM549107patient 135, normal, homogenized [OPG study]6.4812465
GSM549115patient 068, normal, homogenized [OPG study]6.3038863
GSM549116patient 072, normal, homogenized [OPG study]6.7461368
GSM549120patient 078, normal, homogenized [OPG study]6.4513865
GSM549131patient 030, cancer, homogenized [OPG study]5.9607358
GSM549118patient 074, normal, homogenized [OPG study]6.0892959
GSM549129patient 027, cancer, homogenized [OPG study]6.7113867
GSM549123patient 088, normal, homogenized [OPG study]6.5243465
GSM549124patient 006, cancer, homogenized [OPG study]6.6626668
GSM549126patient 015, cancer, homogenized [OPG study]5.8796856
GSM549128patient 025, cancer, homogenized [OPG study]6.3856763
GSM549103patient 117, normal, homogenized [OPG study]6.5634366
GSM549117patient 073, normal, homogenized [OPG study]6.6930168
GSM549138patient 041, cancer, homogenized [OPG study]6.3348863
GSM549141patient 045, cancer, homogenized [OPG study]6.8350469
GSM549130patient 028, cancer, homogenized [OPG study]5.9785658
GSM549101patient 111, normal, homogenized [OPG study]6.056959
GSM549105patient 128, normal, homogenized [OPG study]6.1772461
GSM549106patient 134, normal, homogenized [OPG study]6.4321964
GSM549112patient 048, normal, homogenized [OPG study]6.3536263
GSM549125patient 011, cancer, homogenized [OPG study]6.1796961
GSM549127patient 024, cancer, homogenized [OPG study]6.1704660
GSM549135patient 035, cancer, homogenized [OPG study]6.3515563